As at Jul 25, 2024, the MRK stock has a PE ratio of 138.3. This is based on the current EPS of $0.91 and the stock price of $125.85 per share. A decrease of 49% has been recorded in the PE ratio compared to the average of 268.8 of the last four quarters.
The mean historical PE ratio of Merck over the last ten years is 56.57. The current 138.3 P/E ratio is 144% higher than the historical average. In the past ten years, MRK's PE ratio peaked in the Dec 2023 quarter at 778.71, with a price of $109.02 and an EPS of $0.14. The Sep 2015 quarter marked the lowest point at 13.1, with a price of $49.39 and an EPS of $3.77.
Maximum annual increase: 3,922.26% in 2023
Maximum annual decrease: -58.98% in 2014
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 778.71 | 3,922.26% |
| 2022 | 19.36 | 30.37% |
| 2021 | 14.85 | -49.35% |
| 2020 | 29.32 | 23.82% |
| 2019 | 23.68 | -27.47% |
| 2018 | 32.65 | -48.94% |
| 2017 | 63.94 | 54.22% |
| 2016 | 41.46 | 24.02% |
| 2015 | 33.43 | 142.6% |
| 2014 | 13.78 | -58.98% |
The current PE ratio of MRK is above the 3, 5 and 10-year averages.
MRK's PE ratio stands higher than its peer stocks LLY and JNJ. Merck's current PE ratio of 138.3 is similar to the average of its peer group, which is 26.17.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| NVS Novartis AG | 13.96 | $225.1B |
| ABT Abbott Laboratories | 32.58 | $183.08B |
| AMGN Amgen Inc | 47.58 | $179.67B |
| LLY ELI LILLY & Co | 117.98 | $764.72B |
| MRK Merck & Co Inc | 137.65 | $317.26B |
| PFE Pfizer Inc | N/A | $174.36B |
| BMY Bristol Myers Squibb Co | N/A | $102.27B |
| TEVA Teva Pharmaceutical Industries Ltd | N/A | $19.37B |
As of Jul 25, 2024, MRK stock has a price to earnings ratio of 138.3.
The average PE ratio for MRK stock over the past 3 years is 109.03.
The average PE ratio for MRK stock over the past 5 years is 73.42.
Over the last ten years, the quarterly PE ratio reached a historic high of 778.71 in the Dec 2023 quarter.
MRK's current price to earnings ratio is 144% above its 10-year historical average.
MRK's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 25, 2024), Merck's stock price is $125.85. The earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $0.91. Therefore, Merck's PE ratio for today is 138.3. PE RATIO(138.3) = STOCK PRICE($125.85) / TTM EPS($0.91)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.